Quick Takeaways
- Marc Rubin has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $76,271.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Marc Rubin and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CRIS | CURIS INC | Director | $76,271 | 20 Mar 2026 | ||
| GALT | GALECTIN THERAPEUTICS INC | Director | 23 Jan 2025 | |||
| SHWZ | Medicine Man Technologies, Inc. | Incorrect Filing | 28 Oct 2022 | |||
| TTNP | TITAN PHARMACEUTICALS INC | Executive Chairman, Director | 05 Jan 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|